生体吸収性インプラントの世界市場-2022-2029

市場力学

競合他社がFDA認可取得に注力していることが市場の牽引役となる見込み

近年、様々な適応症に対する実現可能な代替手段として、多くの生体吸収性インプラントが利用できるようになりました。これらの生体吸収性インプラントは、人体内で溶解し、天然の骨と置換されます。ある程度大きなインプラントでは、より良い血管供給のために、インプラントと一体化した相互接続多孔質アセンブリが必要です。アディティブ・マニュファクチャリング技術により、この相互接続多孔質構造を直接製造することができます。市場の主要な競合他社は、患者を治療するための新しい製品のFDA認可を得ることに力を注いでいます。例えば、ボストン・サイエンティフィック社は、プラチナとクロムの金属で構成された「SYNERGY生体吸収性ポリマー薬剤溶出ステントシステム」を発売しました。このステントは、その最適な治癒特性と複雑な症例に対する治療オプションにより、世界中の医師から高い評価を得ています。また、2021年5月23日のプレスリリースによると、Bioretec Ltd.は、外傷学および整形外科で使用するRemeOs ScrewsのFDAブレークスルーデバイス指定を取得しました。新製品は、骨折および変形や不整列の矯正を目的としています。生体活性合金から作られたこのネジは、マグネシウム、亜鉛、カルシウムなど、体にもともと備わっている元素を含んでおり、新しい骨の形成を促進するのに役立ちます。2020年3月23日、Durysta（ビマトプロストインプラント）は、開放隅角緑内障または高眼圧症の患者の治療薬として米国食品医薬品局（FDA）から承認を取得しました。このインプラントは、眼内に直接投与され、ビマトプロストを長期間にわたって放出するものです。したがって、上記の記述から、予測期間中に市場を牽引することが期待されます。

抑制要因

システムのメンテナンスとインストールにかかる高いコスト、アウトソーシングプロセスのコントロールを失う恐れ、データセキュリティとサービス品質に関する懸念、経済戦略の急速な変化などが、予測期間中に市場が阻害される要因のいくつかであると考えられています。

産業分析

生体吸収性インプラント市場は、アンメットニーズ、価格分析、サプライチェーン分析、規制分析など、様々な業界要因に基づく市場の詳細な分析を提供します。

COVID-19の影響分析

COVID-19のパンデミックは、世界の生体吸収性インプラント市場に大きな影響を与えました。パンデミックは世界的にヘルスケアシステムに負担をかけ、病院は整形外科手術などの選択的手術を延期し、生体吸収性インプラントの需要を制限したのです。COVID-19は、化学および材料産業の操業を制限し、世界市場を阻害しています。サプライチェーンの混乱や原材料の調達難は、生体吸収性インプラント市場をやや抑制しています。こうした短期的な課題にもかかわらず、生体吸収性インプラントの世界市場は今後数年間で大きな成長を遂げると予想されます。

生体吸収性インプラントの世界市場レポートでは、約45+市場データ表、40+図、180ページの構成で提供しています。

目次

第1章 調査手法と調査範囲

• 調査手法
• 調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

• 材料タイプ別市場内訳
• アプリケーション別市場内訳
• エンドユーザー別市場内訳
• 地域別市場内訳

第4章 市場力学

• 市場影響要因
• 促進要因
• 抑制要因
• 影響度分析

第5章 産業別フォース

• ポーターのファイブフォース分析
• サプライチェーン分析
• 疫学
• 主な動向と発展状況

第6章 COVID-19分析別

• COVID-19の市場分析

第7章 材料タイプ別

• 金属系
• 高分子材料
• PLGA-ポリ乳酸-グリコール酸
• PLLA-ポリL-ラクチド
• PGA-ポリグリコール酸
• PLAポリ乳酸
• その他

第8章 用途別

• 循環器
• 整形外科
• その他

第9章 エンドユーザー別

• 病院
• 外来手術センター
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米地域
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他の欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第11章 競合情勢

• 競合シナリオ

第12章 企業プロファイル

• Bioretec Ltd
  • 企業概要
  • 製品ポートフォリオと説明
  • 主なハイライト
  • 財務概要
• Stryker Corporation（Wright Medical）
• ConMed Corporation
• Syntellix AG
• Johnson & Johnson Medical Devices（DePuy Synthes）
• Zimmer Biomet Holdings
• Becton, Dickinson and Company（C.R. Bard）
• NuVasive Inc.
• KLS Martin
• Smith & Nephew
• Medtronic Plc

第13章 DataM

Market Overview

Bioresorbable Implants Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 7.40% during the forecast period (2022-2029).

Bioabsorbable implants are the ones that absorb in the body. Bioresorbable materials used for the implants slowly diffuse in the human body, so a second surgery to remove the Synthetic material is not required. The materials used in bioabsorbable implants can be synthetic and natural. Bioabsorbable implants have a wide range of indications, from ocular implants to fixations of bone grafts.

Market Dynamics

Leading Competitors in the market are concentrating their efforts on obtaining FDA clearance is expected to drive the market.

Recently, many bioresorbable implants have been made available as a feasible alternative to various indications. These bioresorbable implants dissolve in the human body and then get replaced by natural bones. For the somewhat large implants, interconnecting porous assembly is needed so that it can be integrated with the implant for better vascularization. The additive manufacturing technology, this interconnecting porous structure can be manufactured directly. The leading competitors in the market are concentrating their efforts on obtaining FDA clearance for novel products to treat patients. For instance, Boston Scientific launched its SYNERGY Bioabsorbable Polymer Drug-Eluting Stent System consisting of platinum and chromium metals. This stent is highly accepted amongst physicians worldwide because of its optimal healing property and treatment options for complex cases. Also, on May 23, 2021, Bioretec Ltd. received FDA breakthrough device designation of its RemeOs Screws for use in traumatology and orthopedic surgery, according to a press release. The new products are intended for bone fractures and for correcting deformities or malalignments. Created from a bioactive alloy, the screws contain elements natural to the body, like magnesium, zinc and calcium, which help promote new bone formation. On March 23, 2020, Durysta (bimatoprost implant) received approval from the US Food and Drug Administration (FDA) for treating patients with open-angle glaucoma or ocular hypertension. The implant is administered directly into the eye, where it releases bimatoprost for an extended period. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

The high cost of system maintenance and installation, the fear of losing control over the outsourced process, concerns about data security and service quality, and rapid changes in economic strategies are some factors the market is expected to get hampered in the forecast period.

Industry Analysis

The bioresorbable implants market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic had a major impact on the global bioabsorbable implants market. The pandemic burdened healthcare systems globally and hospitals postponed elective surgeries such as orthopedic surgeries, restricting the demand for bioresorbable implants. COVID-19 has limited the operations of the chemicals and materials industry, hampering the global market. Supply chain disruptions and difficulty in procuring raw materials have somewhat restrained the bioresorbable implants market. Despite these short-term challenges, the global bioabsorbable implants market is expected to generate significant growth in the coming years.

Segment Analysis

PLGA- Poly lactic-co-glycolic acid segment is expected to be the dominant segment in the market during the forecast period.

The PLGA- Poly lactic-co-glycolic acid segment accounted for the largest market share in 2021. PLGA- Poly lactic-co-glycolic acid is one of the most strongly biodegradable polymers. It is an FDA-approved Generally Recognized as Safe (GRAS) polymer used in various resorbable surgical devices such as meshes, sutures and ligatures. PLGA is a copolymer for drug delivery owing to its mechanical properties, biodegradability, biocompatibility, and ease of processing. It has been used to provide various vascular tissue-engineering devices, such as grafts and prosthetic devices. Early generations of PGA resorbable implants have been known to cause local effects during bio-absorption, and the rapid degeneration of the implants may cause uncertainty before healing occurs. Specifically, PLGA materials are also developed for the dental field in films, membranes, nanoparticles or microparticles. PLGA membranes have been studied with promising results, alone or combined with other elements in bone healing procedures. Biocompatibility, flexibility, biodegradability and minimal side effects are the main benefits when using this polymer for biomedical applications. In particular, PLGA has mainly been studied to develop devices for the controlled delivery of small molecule drugs, proteins and other macromolecules in commercial use and research. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

Geographical Analysis

North American region is expected to hold the largest market share in the global bioresorbable implants market.

The North American bioabsorbable implants market is expected to hold the largest regional share of the global market, owing to factors such as a high prevalence of cardiovascular disease and an increase in the geriatric population, which is expected to increase the number of cases of osteoporosis and osteoarthritis. Technological advancement in bioabsorbable implants, increasing medical innovation and approval of new implants by the FDA are also factors driving the growth of the North American market. For instance, Stryker has developed a new bioabsorbable implant, SonicAnchor, used for suture and tissue fixation. The implant employs ultrasonic energy to liquefy and flow into the cancellous bone for secure fixing. The device is suitable for suture or tissue fixation in ankle, foot, knee, wrist, hand, elbow, and shoulder open operations. Manufacturers are combining strategies to improve patient care. Moreover, in June 2022, a team of researchers from Northwestern University developed a new type of flexible bioabsorbable implant that relieves pain in patients without using drugs.

Competitive Landscape

Major key players in the bioresorbable implants market are Bioretec Ltd, Stryker Corporation, ConMed Corporation, Syntellix AG, Johnson & Johnson, Zimmer Biomet, Becton Dickinson and Company, KLS Martin, Smith and Nephew and Evonik Industries AG, among others.

Bioretec Ltd.:

Overview:

Bioretec Ltd. is a medical device company focusing on developing strong, safe and reliable bioabsorbable and bioresorbable implants for pediatric and adult orthopedics. The company's products are used worldwide, and it continues to develop materials and products for load-bearing further clinical applications. The company's work is under ISO 13485:2016 and FDA Part 820. All the Activa products hold CE certificates, and most are also 510(k) cleared by the FDA.

Product Portfolio:

RemeOs Screw bioresorbable magnesium implants: RemeOs bioresorbable metallic implants are in the clinical testing phase. These implants will offer a strong and bioresorbable solution for load-bearing medical operations. These implants eliminate implant removal while still maintaining strength and rigidity close to traditional steel or titanium implants.

The global bioresorbable Implants market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

• 1.1. Research methodology
• 1.2. Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Market Snippet by Material Type
• 3.2. Market Snippet by Application
• 3.3. Market Snippet by End-User
• 3.4. Market Snippet by Region

4. Market Dynamics

• 4.1. Market Impacting Factors
• 4.2. Drivers
• 4.3. Restraints
• 4.4. Impact Analysis

5. Industry Forces

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Epidemiology
• 5.4. Key Trends and Developments

6. By COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market

7. By Material Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
  • 7.1.2. Market Attractiveness Index, By Material Type
• 7.2. Metallic*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Million, 2019-2027 and Y-o-Y Growth Analysis (%), 2020-2027
• 7.3. Polymers
  • 7.3.1. Introduction
  • 7.3.2. Market Size Analysis, US$ Million, 2019-2027 and Y-o-Y Growth Analysis (%), 2020-2027
• 7.4. PLGA- Polylactic-co-glycolic acid
• 7.5. PLLA- Poly L-lactide
• 7.6. PGA- Polyglycolic Acid
• 7.7. PLA- Polylactic Acid
• 7.8. Others

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Cardiovascular*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2019-2027 and Y-o-Y Growth Analysis (%), 2020-2027
• 8.3. Orthopedics
• 8.4. Others

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis, US$ Million, 2019-2027 and Y-o-Y Growth Analysis (%), 2020-2027
• 9.3. Ambulatory Surgical Centers
• 9.4. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
  • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. South America
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
  • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Brazil
    • 10.3.6.2. Argentina
    • 10.3.6.3. Rest of South America
• 10.4. Europe
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
  • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Germany
    • 10.4.6.2. U.K.
    • 10.4.6.3. France
    • 10.4.6.4. Spain
    • 10.4.6.5. Italy
    • 10.4.6.6. Rest of Europe
• 10.5. Asia Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
  • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia Pacific
• 10.6. Middle East & Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
  • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario

12. Company Profiles

• 12.1. Bioretec Ltd*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Key Highlights
  • 12.1.4. Financial Overview
• 12.2. Stryker Corporation (Wright Medical)
• 12.3. ConMed Corporation
• 12.4. Syntellix AG
• 12.5. Johnson & Johnson Medical Devices (DePuy Synthes)
• 12.6. Zimmer Biomet Holdings
• 12.7. Becton, Dickinson and Company (C.R. Bard)
• 12.8. NuVasive Inc.
• 12.9. KLS Martin
• 12.10. Smith & Nephew
• 12.11. Medtronic Plc

13. DataM Intelligence

• 13.1. Appendix
• 13.2. About Us and Services
• 13.3. Contact Us